|  Help  |  About  |  Contact Us

Publication : Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta.

First Author  Kuzuya A Year  2016
Journal  BMC Biol Volume  14
Pages  25 PubMed ID  27036734
Mgi Jnum  J:232854 Mgi Id  MGI:5780348
Doi  10.1186/s12915-016-0248-3 Citation  Kuzuya A, et al. (2016) Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta. BMC Biol 14:25
abstractText  BACKGROUND: Synaptic loss strongly correlates with memory deterioration. Local accumulation of amyloid beta (Abeta) peptide, and neurotoxic Abeta42 in particular, due to abnormal neuronal activity may underlie synaptic dysfunction, neurodegeneration, and memory impairments. To gain an insight into molecular events underlying neuronal activity-regulated Abeta production at the synapse, we explored functional outcomes of the newly discovered calcium-dependent interaction between Alzheimer's disease-associated presenilin 1 (PS1)/gamma-secretase and synaptic vesicle proteins. RESULTS: Mass spectrometry screen of mouse brain lysates identified synaptotagmin 1 (Syt1) as a novel synapse-specific PS1-binding partner that shows Ca(2+)-dependent PS1 binding profiles in vitro and in vivo. We found that Abeta level, and more critically, conformation of the PS1 and the Abeta42/40 ratio, are affected by Syt1 overexpression or knockdown, indicating that Syt1 and its interaction with PS1 might regulate Abeta production at the synapse. Moreover, beta-secretase 1 (BACE1) stability, beta- and gamma-secretase activity, as well as intracellular compartmentalization of PS1 and BACE1, but not of amyloid precursor protein (APP), nicastrin (Nct), presenilin enhancer 2 (Pen-2), or synaptophysin (Syp) were altered in the absence of Syt1, suggesting a selective effect of Syt1 on PS1 and BACE1 trafficking. CONCLUSIONS: Our findings identify Syt1 as a novel Ca(2+)-sensitive PS1 modulator that could regulate synaptic Abeta, opening avenues for novel and selective synapse targeting therapeutic strategies.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression